×
Back to Agenda
Pandemic Preparedness: Accelerating Treatments to Overcome Antimicrobial Resistance
Session Chair(s)
Lisa Wittmer, PHD
President, Theorogen Consulting, United States
Antimicrobial resistance (AMR) is a threat to global health. Reactive efforts to address AMR risks lives, economies, and security. A proactive preparedness model relies on innovation in development and regulatory pathways.
Learning Objective : Review the current regulatory framework in the context of increasing AMR; Discuss regulator’s role in ensuring development feasibility; Identify areas for improvement.
Speaker(s)
Sumathi Nambiar, MD, MPH
Senior Director, Child Health and Innovation Leadership Department, Johnson & Johnson, United States
Pandemic Preparedness: Accelerating Treatments to Overcome Antimicrobial Resistance
Marco Cavaleri, PHD
Head of Health Threats and Vaccines Strategy, European Medicines Agency, Netherlands
EMA Update
Paul Christopher McGovern
Vice President, Medical Sciences, Venatorx Pharmaceuticals, Inc., United States
Panelist
Have an account?